US$2,224.00
Jan 2010
World Smoking-Cessation Drug Market 2010-2025
Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare systems, as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice, with the reputation of some suffering through noted side-effects. As a result, there are significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents, especially in prescription form.
Order Now
|
More Information
|
Tell-a-Friend
US$3,400.00
Aug 2009
Cell-Based Assays for Drug Discovery
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications that require sufficient levels of sample throughput, whereby complex cellular events and phenotypes can be studied. Elements of drug performance like toxicity and specificity can be established simultaneously using mixed cell types—primary cells, cell lines, cell subpopulations. HCS seeks to assess the impact of phenotypic and cellular changes that are brought about by gene modification (such as with RNA interference (RNAi) approaches) and/or drug (or compound) treatment. The purpose of this examination by TriMark Publications is to describe the specific segments of the global drug discovery tools market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this study examines the markets for small lab equipment all the way up to highly automated, large automated platforms, as well as accessory equipment such as reagents, supplies and manufacturers’ original equipment manufacturer (OEM) additional equipment.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
US Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
UK Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
Indian Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
Chinese Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
Japanese Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
German Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
France Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
Australian Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$600.00
Jun 2009
Canadian Drug Sector: Industry Profile
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals.
Order Now |
More Information |
Tell-a-Friend
US$15,200.00
Apr 2009
Nicotine Dependence Market Forecast
With a considerable patient population and continued government focus on lowering national smoking rates, the nicotine dependence market represents a lucrative opportunity for pharmaceutical companies. With strong uptake since launch in 2006 of Pfizer's Chantix (varenicline), the seven major prescription nicotine dependence market was estimated to total $1.35 billion in 2008.
Order Now |
More Information |
Tell-a-Friend
US$15,200.00
Mar 2009
Opioids Market Forecast
The opioids market is set to grow from $9.6 billion in 2008 to $11.9 billion in 2018 across the seven major markets. However, the number and diversity of products in late-stage development will limit the commercial potential of individual brands simply due to saturation and price competition in each opioids market.
Order Now |
More Information |
Tell-a-Friend
US$2,224.00
Mar 2009
Smoking Cessation Report 2009-2024
Smoking is the leading cause of preventable death in the world. The effects of smoking represent a global pandemic of enormous proportions. Currently-marketed smoking cessation aids typically lack high levels of efficacy in practice and are associated with marked side-effects. There are clear market opportunities for novel, more-efficacious and safer smoking cessation agents, in both prescription and OTC forms.
Order Now |
More Information |
Tell-a-Friend
US$2,224.00
Nov 2008
The Global Anti-Addiction Market, 2008-2023
The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents? The brand new report, The Global Anti-Addiction Market, 2008-2023, provides an in-depth analysis of the current state of the market for addiction therapy drugs, from the present looking forward. It covers the major therapy areas of smoking cessation, obesity, drug addiction and alcohol dependency. In addition, this study forecasts how your market will grow and develop, both quantitatively and qualitatively, during the period 2008-2023.
Order Now |
More Information |
Tell-a-Friend
US$3,800.00
May 2008
Drug Repositioning Strategies - Serendipity by design
Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment. As competition to inlicense candidates drives the price of this strategy up, repositioning presents a cost effective alternative.
Order Now |
More Information |
Tell-a-Friend
US$7,600.00
Dec 2007
Pipeline Insight: Substance Dependence - Part II: Alcohol
The continued uptake of existing brands and the launch of two opioid antagonists will cause the market to grow at a compound annual growth rate of 13.5% from 2006 to reach $304m across the seven major markets by 2016. The alcohol dependence market requires a paradigm shift away from the public perception that it is a behavioral disorder towards being regarded as a treatable medical condition.
Order Now |
More Information |
Tell-a-Friend
